Risk Factors Associated with the Clinical Outcomes of COVID-19 and Its Variants in the Context of Cytokine Storm and Therapeutics/Vaccine Development Challenges
The recent appearance of SARS-CoV-2 is responsible for the ongoing coronavirus disease 2019 (COVID-19) pandemic and has brought to light the importance of understanding this highly pathogenic agent to prevent future pandemics. This virus is from the same single-stranded positive-sense RNA family, Co...
Main Authors: | John Hanna, Padmavathi Tipparaju, Tania Mulherkar, Edward Lin, Victoria Mischley, Ratuja Kulkarni, Aliyah Bolton, Siddappa N. Byrareddy, Pooja Jain |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/9/8/938 |
Similar Items
-
Immune system response during viral Infections: Immunomodulators, cytokine storm (CS) and Immunotherapeutics in COVID-19
by: Faheem Hyder Pottoo, et al.
Published: (2021-02-01) -
Therapeutic Role of Tocilizumab in SARS-CoV-2-Induced Cytokine Storm: Rationale and Current Evidence
by: Corrado Pelaia, et al.
Published: (2021-03-01) -
The Immune Response and Immunopathology of COVID-19
by: Esmaeil Mortaz, et al.
Published: (2020-08-01) -
Coronaviruses: Is Sialic Acid a Gate to the Eye of Cytokine Storm? From the Entry to the Effects
by: Przemyslaw Wielgat, et al.
Published: (2020-08-01) -
Pulmonary involvement and cytochemical storm: beyond SARS-CoV-2 pneumoniae
by: Ombretta Para, et al.
Published: (2020-12-01)